Authors:
BUJDAKOVA H
LAUSOVA A
JANKOVICOVA S
PRODINGER WM
KALLOVA J
MILOSOVIC P
KETTNER M
Citation: H. Bujdakova et al., STUDY OF BETA-LACTAM RESISTANCE IN CEFTAZIDIME-RESISTANT CLINICAL ISOLATES OF ENTEROBACTERIACEAE, International journal of antimicrobial agents, 10(2), 1998, pp. 135-141
Citation: Wm. Prodinger et al., THE C-TERMINUS OF FACTOR-H - MONOCLONAL-ANTIBODIES INHIBIT HEPARIN-BINDING AND IDENTIFY EPITOPES COMMON TO FACTOR-H AND FACTOR H-RELATED PROTEINS, Biochemical journal, 331, 1998, pp. 41-47
Authors:
PRODINGER WM
SCHWENDINGER MG
SCHOCH J
KOCHLE M
LARCHER C
DIERICH MP
Citation: Wm. Prodinger et al., CHARACTERIZATION OF C3DG BINDING TO A RECESS FORMED BETWEEN SCR-1 ANDSCR-2 OF COMPLEMENT RECEPTOR-TYPE-2, Molecular immunology, 35(6-7), 1998, pp. 248-248
Citation: Mg. Schwendinger et al., CR-2-DEPENDENT ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - EFFICACY OF THE CR-2-ASSOCIATED INITIAL C3-CONVERTASE IC3BBP, Molecular immunology, 35(6-7), 1998, pp. 249-249
Citation: Wm. Prodinger et al., THE C-TERMINUS OF FACTOR-H - MONOCLONAL-ANTIBODIES INHIBIT HEPARIN-BINDING AND IDENTIFY EPITOPES COMMON TO FACTOR-H AND FACTOR-H RELATED PROTEINS, Molecular immunology, 35(6-7), 1998, pp. 250-250
Authors:
PRODINGER WM
SCHWENDINGER MG
SCHOCH J
KOCHLE M
LARCHER C
DIERICH MP
Citation: Wm. Prodinger et al., CHARACTERIZATION OF C3DG BINDING TO A RECESS FORMED BETWEEN SHORT CONSENSUS REPEATS 1 AND 2 OF COMPLEMENT RECEPTOR-TYPE 2 (CR-2, CD21), The Journal of immunology (1950), 161(9), 1998, pp. 4604-4610
Citation: Wm. Prodinger et al., EXPRESSION IN INSECT CELLS OF THE FUNCTIONAL DOMAIN OF CD21 (COMPLEMENT RECEPTOR-TYPE-2) AS A TRUNCATED SOLUBLE MOLECULE USING A BACULOVIRUS VECTOR, Immunopharmacology, 38(1-2), 1997, pp. 141-148
Authors:
SCHRATZBERGER P
REINISCH N
PRODINGER WM
KAHLER CM
SITTE BA
BELLMANN R
FISCHERCOLBRIE R
WINKLER H
WIEDERMANN CJ
Citation: P. Schratzberger et al., DIFFERENTIAL CHEMOTACTIC ACTIVITIES OF SENSORY NEUROPEPTIDES FOR HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, The Journal of immunology, 158(8), 1997, pp. 3895-3901
Citation: Mg. Schwendinger et al., A NOVEL MECHANISM OF ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION ACCOUNTS FOR THE DEPOSITION OF C3 FRAGMENTS ON CR-2-EXPRESSING HOMOLOGOUS CELLS, The Journal of immunology, 158(11), 1997, pp. 5455-5463
Authors:
PRODINGER WM
FILLE M
BAUERNFEIND A
STEMPLINGER I
AMANN S
PFAUSLER B
LASSFLORL C
DIERICH MP
Citation: Wm. Prodinger et al., MOLECULAR EPIDEMIOLOGY OF KLEBSIELLA-PNEUMONIAE PRODUCING SHV-5 BETA-LACTAMASE - PARALLEL OUTBREAKS DUE TO MULTIPLE PLASMID TRANSFER, Journal of clinical microbiology, 34(3), 1996, pp. 564-568
Authors:
PRODINGER WM
LARCHER C
SCHWENDINGER M
DIERICH MP
Citation: Wm. Prodinger et al., LIGATION OF THE FUNCTIONAL DOMAIN OF COMPLEMENT RECEPTOR-TYPE-2 (CR-2, CD21) IS RELEVANT FOR COMPLEX-FORMATION IN T-CELL LINES, The Journal of immunology, 156(7), 1996, pp. 2580-2584
Authors:
LARCHER C
JULEN N
PRODINGER WM
TOTSCH M
GURTLER L
DIERICH MP
Citation: C. Larcher et al., REDUCED CD21(CR2) AND CD54 (ICAM-1) EXPRESSION IN MT2 CELLS WITH HIV-1 OR HIV-2 STRAINS, Immunology letters, 46(1-2), 1995, pp. 31-36
Authors:
LARCHER C
KEMPKES B
KREMMER E
PRODINGER WM
PAWLITA M
BORNKAMM GW
DIERICH MP
Citation: C. Larcher et al., EXPRESSION OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2) INDUCES CD21 CR2 ON B-CELL AND T-CELL LINES AND SHEDDING OF SOLUBLE CD21/, European Journal of Immunology, 25(6), 1995, pp. 1713-1719
Authors:
PRODINGER WM
LARCHER C
SOLDER BM
GEISSLER D
DIERICH MP
Citation: Wm. Prodinger et al., HEPATITIS-A IN WESTERN AUSTRIA - THE EPIDEMIOLOGIC SITUATION BEFORE THE INTRODUCTION OF ACTIVE IMMUNIZATION, Infection, 22(1), 1994, pp. 53-55
Authors:
PRODINGER WM
BONATTI H
ALLERBERGER F
WEWALKA G
HARRISON TG
AICHBERGER C
DIERICH MP
MARGREITER R
TIEFENBRUNNER F
Citation: Wm. Prodinger et al., LEGIONELLA-PNEUMONIA IN TRANSPLANT RECIPIENTS - A CLUSTER OF CASES OF8 YEARS DURATION, The Journal of hospital infection, 26(3), 1994, pp. 191-202
Authors:
PUCHHAMMERSTOCKL E
HEINZ FX
PRODINGER WM
KUNZ C
Citation: E. Puchhammerstockl et al., EARLY DIAGNOSIS OF PERINATALLY ACQUIRED HIV-INFECTION BY THE POLYMERASE CHAIN-REACTION, Wiener Klinische Wochenschrift, 105(15), 1993, pp. 429-432
Authors:
HUEMER HP
LARCHER C
PRODINGER WM
PETZER AL
MITTERER M
FALSER N
Citation: Hp. Huemer et al., DETERMINATION OF SOLUBLE CD21 AS A PARAMETER OF B-CELL ACTIVATION, Clinical and experimental immunology, 93(2), 1993, pp. 195-199